IWC
JAZZ icon

Integrated Wealth Concepts’s Jazz Pharmaceuticals JAZZ Stock Holding History

Integrated Wealth Concepts’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Buy
+1,385
New +$242K ﹤0.01% 1939
2025
Q3 		– Sell
-4,864
Closed -$516K – 2034
2025
Q2 		$516K Buy
+4,864
New +$528K 0.01% 1257

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Integrated Wealth Concepts's JAZZ Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 1,385 shares worth $262K. The stake represents ﹤0.01% of the portfolio and ranks #1939 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in JAZZ as recently as Q2 2025.

Integrated Wealth Concepts first reported a position in JAZZ in Q2 2025 and has held it in 2 quarters since. The position peaked at $516K in Q2 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Integrated Wealth Concepts held 1,385 shares of Jazz Pharmaceuticals worth $262K as of Q1 2026.
  • Jazz Pharmaceuticals was a new Integrated Wealth Concepts position in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #1939 holding.
  • Integrated Wealth Concepts first reported a position in Jazz Pharmaceuticals in Q2 2025 and has held it in 2 quarters since.
  • Integrated Wealth Concepts's Jazz Pharmaceuticals position peaked at $516K in Q2 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.